MedPharm, a global Contract Development and Manufacturing Organization that specializes in topical and transdermal drug product development, recently completed a Medicines and Healthcare products Regulatory Agency (MHRA) GMP audit of its Guildford locations. We are happy to announce there were no critical or major findings from the audit.

These evaluations of MedPharm’s systems and compliance with regulatory standards are further confirmation of MedPharm’s commitment to providing the gold standard in topical development and manufacturing services.

To learn more about MedPharm’s capabilities, view our virtual facility tours or contact our team today.